Fox Jennifer Lynne

SEC source: 0001914879-26-000004 · wk-form4_1788898728.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,964

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026.

SEC source: 0001914879-26-000002 · wk-form4_1773695152.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,362

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

SEC source: 0001914879-26-000002 · wk-form4_1773695152.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,357

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001914879-25-000004 · wk-form4_1757016855.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,481

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 3, 2025.

SEC source: 0001628280-25-013147 · wk-form4_1742242778.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,916

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001914879-24-000007 · wk-form4_1725487665.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,771

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001367644-24-000126 · wk-form4_1720816385.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,382

F1 · shares: Consists of restricted stock units granted under the company's Amended and Restated Stock Incentive Plan. These restricted stock units vest in one installment on the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-24-000108 · wk-form4_1718136649.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,382

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000042 · wk-form4_1710537351.xml · derivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,169

Underlying: Common Stock · 125,000 shares

Expires 2031-03-12

F1 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-24-000019 · wk-form4_1709595745.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,758

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000019 · wk-form4_1709595745.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,461

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-24-000010 · wk-form4_1709083709.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,564

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000191 · wk-form4_1700008089.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,793

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · derivative · entry 3

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,169

Underlying: Common Stock · 49,231 shares

Expires 2030-06-08

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,206

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000123 · wk-form4_1686705732.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,975

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · derivative · entry 3

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,938

Underlying: Common Stock · 12,308 shares

Expires 2030-03-01

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

F4 · balance_after: Represents the corrected number of securities owned due to a computational error on prior Form-4.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,359

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-23-000067 · wf-form4_167814934737010.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,051

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-23-000060 · wf-form4_167778621301638.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,897

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000034 · wf-form4_167754734539183.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,902

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000034 · wf-form4_167754734539183.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,160

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-22-000155 · wf-form4_167096987928470.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,391

F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the day prior to the second anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000155 · wf-form4_167096987928470.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,256

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-22-000146 · wf-form4_166854681352678.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,211

F1 · shares: Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022.

SEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · derivative · entry 3

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,584

Underlying: Common Stock · 26,584 shares

Expires 2029-02-28

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,627

F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (8,713 shares) or on the day prior to the second anniversary date of the grant (9,063 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,833

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.